Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Avextra logo — Our vision: the leading European Producer of Medicinal Canna...

Avextra

Our vision: the leading European Producer of Medicinal Cannabis products. Improving the lives of millions of people.

Founded 2019 Germany Bensheim, Germany 42 employees Venture round Manufacturing

General Information

Company Name Avextra
Founded Year 2019
Location Germany Bensheim, Germany
Employees 42
Industries Manufacturing
Funding Stage Venture round
Business Model B2B2C, B2B
Revenue Model Product Sales, One Time Purchase, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Avextra. To contact Avextra, visit avextra.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Avextra compare?

A PDF of Avextra and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Avextra soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Avextra

Avextra, established in 2019, is a German-based company emerging within the Manufacturing industry. The company is driven by a vision to harness the therapeutic potential of the cannabis plant to enhance patient quality of life.

Guided by its slogan — "The Essence of Cannabis-based Medicine is evidence" — Avextra aims to develop innovative, rigorously tested, and regulator-approved cannabis-based medicines. Their mission focuses on making these pharmaceutical solutions broadly accessible, thus addressing the needs of a wide patient demographic.

Despite being a young entity, Avextra has not specified recent funding rounds or investors, indicating potential opportunities for fresh capital infusion to advance its mission and expand market presence. The blend of scientific research, regulatory compliance, and patient-centric innovation positions Avextra as a compelling consideration for investors interested in the burgeoning cannabis-based therapeutic sector.

Business keywords: Cannabis-based Medicine, Therapeutic Potential, Quality of Life, Pharmaceutical Development, Innovative Products, Regulatory Approval, Standardized Therapeutic Options, Plant-based Medicine, Patient Population, Medical Manufacturing, Secure Solutions, Evidence-based Medicine

Services & Products

Development and manufacturing of cannabis-based medicines
Conducting clinical trials and application studies
Research and development in plant-based pharmaceuticals
Integration of end-to-end supply chain from cultivation to production

Target Customers

Patients with chronic conditions Healthcare professionals and pharmacists Palliative care specialists Medical researchers Pharmaceutical distributors

No funding data available for Avextra yet.

Avextra Alternatives & Competitors

View All Alternatives
Avextra vs
Entourage Lab
Entourage Lab Brazil

First Brazilian company in research and development of Cannabis-based medications.

11 employees
Manufacturing, Pharmaceutical
Avextra vs
GESLabs
GESLabs United Kingdom

Leading Naturally

41 employees
Biotechnology, Health and Wellness
Compare Avextra vs GESLabs
Avextra vs
Australian Natural Therapeutics Group (ANTG)
Australian Natural Therapeutics Group (ANTG) Australia

Dedicated to advancing the cause of plant medicine to provide a high-value health solution to patien...

87 employees
Health Care, Manufacturing
View all alternatives

FAQ About Avextra

Our vision: the leading European Producer of Medicinal Cannabis products. Improving the lives of millions of people.
Avextra was founded in 2019.
Avextra is headquartered in Bensheim, Germany.
Avextra operates in Manufacturing. Its work centres on Cannabis-based Medicine, Therapeutic Potential, Quality of Life and Pharmaceutical Development. Its customers include Patients with chronic conditions, Healthcare professionals and pharmacists and Palliative care specialists.
Avextra has a B2B2C and B2B business model. Its revenue comes from Product Sales, One Time Purchase and Tiered Pricing.
Avextra has approximately 42 employees.
Avextra offers: Development and manufacturing of cannabis-based medicines, Conducting clinical trials and application studies, Research and development in plant-based pharmaceuticals, Integration of end-to-end supply chain from cultivation to production.
Top alternatives and competitors to Avextra include Entourage Lab, GESLabs, Australian Natural Therapeutics Group (ANTG), Lompostran, Alvimedica. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avextra and Entourage Lab are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Avextra, https://bouncewatch.com/company/avextra, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes